This educational activity has been planned in accordance with the AASLD Financial Disclosure Policy and ACCME Standards for the Integrity and Independence for Accredited Continuing Education by members of the AASLD CME Committee, the AASLD Maintenance of Certification Committee and the AASLD Governing Board. As an accredited provider, AASLD must collect information from all planners, faculty and others in the planning and control of continuing medical education (CME) activities to disclose all of their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, in ineligible companies. Individuals must disclose financial relationships with ineligible companies regardless of their view of the relevance of the relationship to the education. The American Association for the Study of Liver Diseases (AASLD) has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair balanced, independent, and free of commercial bias. Conflicts, if any, are resolved through one or more processes.
All relevant conflicts pertaining to this activity have been mitigated. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of AASLD.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
FACULTY:
Alina Allen, MD
Scientific Consultant/Advisor: Ionis Pharmaceuticals, Inc.
Ali Aminian, MD
Scientific Consultant/Advisor: Eli Lilly, Ethicon, Medtronic
Research Grants: Ethicon, Medtronic
Naim Alkhouri, MD, FAASLD:
Scientific Consultant/Advisor: Intercept, Pfizer, Gilead, Echosens, Fibronostics, LG Chem, Novo Nordisk, 89Bio, Akero, Perspectum, Galecto, NorthSea, Merck, Altimmune
Research Grants: 89Bio, Akero, AbbVie/Allergan, Altimmune, Better Therapeutics, Boehringer Ingelheim, Bristol MyersSquibb, Corcept, DSM, Galectin, Genentech, Genfit, Gilead, Hepagene, Healio, Intercept, Inventiva, Ionis, Madrigal, Merck, NGM, Noom, NorthSea, Novo Nordisk, Perspectum, Pfizer, Poxel, Viking, and Zydus
Speakers Bureau: Intercept, Gilead, AbbVie, Alexion, Echosens, Perspectum, Exelixis
Meena Bansal, MD, FAASLD:
Scientific Consultant/Advisor: Kinetix Group; Boehringer-Ingelheim
Fernando Bril, MD:
Scientific Consultant/Advisor: NovoNordisk, Boehringer Ingelheim
Kenneth Cusi, MD, FACP, FACE
Scientific Consultant/Advisor: Aligos Therapeutics, Arrowhead, AstraZeneca, 89Bio, BMS, Boehringer Ingelheim, GSK, Eli Lilly & Co, Novo Nordisk, Prosciento, Sagimet Biosciences, Siemens USA and Terns Pharma Research Grants: Inventiva, Echosens, Boehringer Ingelheim, Perspectum, LabCorp
Luis Antonio Diaz:
Nothing to Disclose
Anna Mae Diehl, MD, FAASLD:
Nothing to Disclose
Pichamol Jirapinyo, MD:
Scientific Consultant/Advisor: Boston Scientific, Cook Medical, ERBE, Fractyl, Spatz Medical
Research Grants: Boston Scientific, GI Dynamics, Fractyl, USGI Medical
Stock Options- Privately Held: Bariando
Jenn Jones, BA
Contractor: Boehringer Ingelheim
Kathy Jung, PhD
Nothing to Disclose
W. Ray Kim, MD, FAASLD
Scientific Consultant/Advisor: Grifols, Gilead Sciences
Aleksander Krag, MD, PhD
Nothing to Disclose
Suthat Liangpunsakul, MD, MPH, AGAF, FAASLD
Scientific Consultant/Advisor: TwoXar, Surrozen, Durect, Korro Bio
Rohit Loomba, MD, MHSc, FAASLD
Employee: LipoNexus
Scientific Consultant/Advisor: Aardvark, Altimmune, Arrowhead, AstraZeneca, Cascade, Eli Lilly, Gilead, Glympse Bio, Inipharma, Intercept, Inventiva, Ionis, Janssen, Lipidio, Madrigal, Neurobo, Novo Nordisk, Merck, Pfizer, Sagimet Biosciences, Takeda, 89bio, Terns, Viking
Research Grants: Arrowhead, AstraZeneca, Boehringer Ingelheim, Bristol Myers-Squibb, Eli Lilly, Galectin Therapeutics, Gilead, Intercept, Hammi, Inventiva, Ionis, Janssen, Madrigal, Merck, Novo Nordisk, Pfizer, Sonic Incytes and Terns
Michael Lucey, MD, FAASLD
Scientific Consultant/Advisor: Novartis
Research Grants: PharmaSolutions; Intercept Pharma; Exact Sciences
Pranoti Mandrekar, PhD, FAASLD
Nothing to Disclose
Philippe Mathurin, MD, PhD
Board Membership: Bristol Myers-Squibb, Gilead, AbbVie, Eisai, Intercept, Ipsen, Bayer, Novo Nordisk, Pfizer
Scientific Consultant/Advisor: Bristol Myers-Squibb, Gilead, AbbVie, Eisai, Intercept, Ipsen, Bayer, Novo Nordisk, Pfizer
Craig McClain, MD, FAASLD
Scientific Consultant/Advisor: US Federal Trade Commission
Research Grants: NIH, VA, Intercept, Target Pharma Solutions, Altimmune
Jessica Mellinger, MD
Scientific Consultant/Advisor: GlaxoSmithKline
Mary Rinella, MD, FAASLD
Scientific Consultant/Advisor: Boehringer Ingelheim, Intercept, GlaxoSmithKline, Eli Lilly, Madrigal, NovoNordisk, Cytodyn, HistoIndex, Sonic Incytes, 89Bio, Akero, NGM Biopharmaceuticals, Sagimet
Juan Pablo Arab, MD, FRCPC
Nothing to Disclose
Jurgen Rehm, MD, FRCPC
Nothing to Disclose
Arun Sanyal, MD, FAASLD
Scientific Consultant/Advisor: Target Pharmasolutions
Research Grants: Astra Zeneca, Intercept, Pfizer, Merck, Bristol Myers Squibb, Eli Lilly, Echosens, Novo Nordisk, Boehringer Ingelheim, Novartis, Madrigal
Intellectual Property Rights: UpToDate, Elsevier
Ashwani Singal, MD, MS, FACS, FAASLD
Scientific Consultant/Advisor: Pleiogenix, GSK, Madrigal, CLD Foundation, Medscape Gastroenterology, Medical Speaker's Network, Up-To-Date Research Grants: American College of Gastroenterology, National Institute of Alcohol Abuse and Alcoholism, Pleiogenix SBIR
Douglas Simonetto, MD
Scientific Consultant/Advisor: Mallinckrodt; BioVie
Tram Tran
Scientific Consultant/Advisor: Gilead, Bristol Myers-Squibb, AbbVie, Merck
Research Grants: Gilead, AbbVie, Bristol Myers-Squibb
Gyongyi Szabo, MD, PhD, FAASLD
Scientific Consultant/Advisor: Analym Pharma, Intercept, Novartis, Generon, Allergan, Glympse Bio
Research Grants: Gilead
Norah Terrault, MD, MPH, FAASLD
Nothing to Disclose
Miriam Vos, MD, MSPH, FAASLD
Scientific Consultant/Advisor: Eli Lilly, Bristol Myers-Squibb, Boehringer Ingelheim, Intercept, Prosciento, Theogenisis
Research Grants: AMRA, Quest, Gemfire, Sonic Incytes
Tiffany Wu, MD, MS
Nothing to Disclose
Zobair Younossi, MD, MPH, FAASLD
Scientific Consultant/Advisor: Gilead, Intercept, Merck, Bristol Meyer, Siemens, Novo Nordisk, Madrigal, Abbott, Cymabay, GlaxoSmithKline
PLANNING COMMITTEE:
Juan Pablo Arab, MD, FRCPC
Nothing to Disclose
Sumeet Asrani, MD, MSc
Nothing to Disclose
Bilal Hameed, MD, FAASLD
Scientific Consultant/Advisor: Mallinckrodt, Pliant Therapeutics
Research Grants: Novo Nordisk, Gilead, Genfit, Pleiogenix, Intercept
Mazen Nourredin, MD, MHSc
Scientific Consultant/Advisor: Altimmune, BI, Cytodyn, Corcept, 89BIO, GSK, Madrigal, Merck, Novo Nordisk, Northsea Therapeutics, Perspectum, Siemens,Terns and Takeda
Research Grants: Allergan, Akero, BMS, BI, Gilead, Galectin, Genfit, GSK, Conatus, Corcept, Enanta, Madrigal, Novartis, Novo Nordisk, Shire, Takeda, Terns, Viking and Zydus
Mary Rinella, MD, FAASLD
Scientific Consultant: Boehringer Ingelheim, Intercept, GlaxoSmithKline, Eli Lilly, Madrigal, NovoNordisk, Cytodyn, HistoIndex, Sonic Incytes, 89Bio, Akero, NGM Biopharmaceuticals, Sagimet
Vijay Shah, MD, FAASLD
Scientific Consultant/Advisor: Novartis Pharma, Generon Shanghai, HepaRegniX, Mallinckrodt, Korro Bio, Seal Rock Therapeutics, Akaza Bioscience, AgomAb Therapeutics, Resolution Therapeutics, Intercept
REVIEWERS AND STAFF:
Steven Folstein, MFA, M.Ed.
Nothing to Disclose
Sally Cook, CMP, CHCP
Nothing to Disclose